WallStSmart

Chime Financial, Inc. Class A Common Stock (CHYM)vsSalesforce.com Inc (CRM)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Salesforce.com Inc generates 1750% more annual revenue ($42.83B vs $2.32B). CRM leads profitability with a 18.7% profit margin vs -41.9%. CRM earns a higher WallStSmart Score of 71/100 (B).

CHYM

Hold

41

out of 100

Grade: D

Growth: 6.7Profit: 3.5Value: 5.0Quality: 6.5
Piotroski: 2/9Altman Z: -0.66

CRM

Strong Buy

71

out of 100

Grade: B

Growth: 7.3Profit: 7.5Value: 7.3Quality: 4.5
Piotroski: 5/9Altman Z: 1.50
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CHYM.

CRMUndervalued (+74.7%)

Margin of Safety

+74.7%

Fair Value

$722.63

Current Price

$185.66

$536.97 discount

UndervaluedFair: $722.63Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CHYM3 strengths · Avg: 8.7/10
Debt/EquityHealth
0.0810/10

Conservative balance sheet, low leverage

Operating MarginProfitability
20.9%8/10

Strong operational efficiency at 20.9%

Revenue GrowthGrowth
24.8%8/10

Revenue surging 24.8% year-over-year

CRM5 strengths · Avg: 8.8/10
EPS GrowthGrowth
52.2%10/10

Earnings expanding 52.2% YoY

Market CapQuality
$164.49B9/10

Large-cap with strong market position

Return on EquityProfitability
23.4%9/10

Every $100 of equity generates 23 in profit

Operating MarginProfitability
21.8%8/10

Strong operational efficiency at 21.8%

Free Cash FlowQuality
$6.56B8/10

Generating 6.6B in free cash flow

Areas to Watch

CHYM4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-67.2%2/10

ROE of -67.2% — below average capital efficiency

EPS GrowthGrowth
-33.8%2/10

Earnings declined 33.8%

Altman Z-ScoreHealth
-0.662/10

Distress zone — elevated risk

CRM2 concerns · Avg: 3.5/10
Altman Z-ScoreHealth
1.504/10

Distress zone — elevated risk

Debt/EquityHealth
1.223/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : CHYM

The strongest argument for CHYM centers on Debt/Equity, Operating Margin, Revenue Growth. Revenue growth of 24.8% demonstrates continued momentum.

Bull Case : CRM

The strongest argument for CRM centers on EPS Growth, Market Cap, Return on Equity. Profitability is solid with margins at 18.7% and operating margin at 21.8%. Revenue growth of 13.3% demonstrates continued momentum.

Bear Case : CHYM

The primary concerns for CHYM are Piotroski F-Score, Return on Equity, EPS Growth.

Bear Case : CRM

The primary concerns for CRM are Altman Z-Score, Debt/Equity.

Key Dynamics to Monitor

CHYM profiles as a growth stock while CRM is a mature play — different risk/reward profiles.

CHYM is growing revenue faster at 24.8% — sustainability is the question.

CRM generates stronger free cash flow (6.6B), providing more financial flexibility.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CRM scores higher overall (71/100 vs 41/100), backed by strong 18.7% margins and 13.3% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Chime Financial, Inc. Class A Common Stock

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Chime Financial, Inc., a financial technology company, provides digital consumer banking and payment solutions. The company is headquartered in San Francisco, California.

Salesforce.com Inc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Salesforce.com, Inc. is an American cloud-based software company headquartered in San Francisco, California. It provides customer relationship management (CRM) service and also provides a complementary suite of enterprise applications focused on customer service, marketing automation, analytics, and application development.

Visit Website →

Want to dig deeper into these stocks?